Related Experiment Video
Updated: Jan 3, 2026

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
Published on: May 16, 2021
New Challenges in Drug Discovery - July 8-11, 2019, Vitoria-Gasteiz, Spain
Concepción Alonso1, Jesús M de Los Santos1, Francisco Palacios1
1Department of Organic Chemistry I Faculty of Pharmacy and Lascaray Research Center, University of the Basque Country (UPV/EHU), Paseo de la Universidad 7, 01006, Vitoria-Gasteiz, Spain.
Abstract:
The 2019 edition "New Challenges in Drug Discovery", one of the biennial meetings under the patronage of the SEQT and EFMC, was held at the Faculty of Pharmacy of the University of the Basque Country in Vitoria-Gasteiz from July 8 to 11, 2019. On this occasion, attendees from Spain as well as from five EU countries and three non-EU countries were spectators of many scientific highlights related with the main research areas for different diseases and with protein-protein interactions, analytical tools and methods in discovery and development of drugs and computer-assisted methods in medicinal chemistry. The interesting scientific program was also complemented by an entertaining social program: a gastronomic opening ceremony held at the Museum of Fine Arts of Alava, visits to the Medieval Old City of Gasteiz and a gala dinner in a typical restaurant nestled in a building from the XVth Century.
More Related Videos
Related Concept Videos
Drug Discovery: Overview
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Preclinical Development: Overview
Clinical Trials: Overview
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...

